Estudo de biomarcadores circulantes no cancro da nasofaringe by Sawsan Feki Pape
79,94 €
A edio TNM (UICC 2017). A sensibilidade do Cyfra 21-1 na CNP (66%) atingiu 100% nos doentes com idade inferior a 30 anos. At The Nile, if you're looking for it, we've got it. We've got this. Audience General.
Jetzt bei Ebay:
![Produktbild - Estudo de biomarcadores circulantes no cancro da nasofaringe [Portuguese]](https://i.ebayimg.com/thumbs/images/g/kMcAAOSwS-dm3e14/s-l140.jpg)
![Produktbild - Estudo Da Dispensa de Medicamentos Anti-Cancro [Portuguese] by Souleymane Maïga](https://i.ebayimg.com/thumbs/images/g/-DYAAOSw651nWNLp/s-l140.jpg)
![Produktbild - Estudo da expressão de TGF-α e EGFR no cancro da tiroide [Portuguese]](https://i.ebayimg.com/thumbs/images/g/XI0AAOSwkW9m3e7X/s-l140.jpg)
![Produktbild - Biomarcadores no cancro da mama [Portuguese] by Pravin Badhe [Paperback]](https://i.ebayimg.com/thumbs/images/g/PeUAAOSwcCFm3e7C/s-l140.jpg)
![Produktbild - Biomarcadores Imunitários Na Pré-Eclâmpsia [Portuguese] by Simmi Kharb](https://i.ebayimg.com/thumbs/images/g/keEAAOSwdKBm3fnM/s-l140.jpg)